Skip to content

ALI in Cancer Patients

Outcomes of Acute Limb Ischemia in Cancer Patients .

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06882187
Acronym
ALI
Enrollment
40
Registered
2025-03-18
Start date
2025-05-01
Completion date
2026-07-01
Last updated
2025-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Limb Ischemia

Brief summary

The aim of the study is to describe and evaluate the outcomes of cancer patients presenting with and treated for ALI at our center .

Detailed description

Acute limb ischemia (ALI) is a vascular emergency and is associated with significant morbidity and mortality. Peripheral arterial embolism or thrombosis from malignant disease is uncommon and a rare cause of acute limb ischemia. Limb ischemia can be caused by emboli from the tumor itself, from metastatic deposits within large vessels, as well as the tumors of adjacent organs such as the lung, which invade the left or right atrium of the heart and then disseminate to the main arteries of the body. This acute event may be the first indication of malignant disease in the patient.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All cancer patient presented to Vascular and Endovascular surgery departement with ALI.

Exclusion criteria

* Patients with benign tumors or without active malignancy. * Patients with iatrogenic limb ischemia related to a tumor chemoembolization procedure.

Design outcomes

Primary

MeasureTime frame
Limb Salvagebaseline

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026